Investigators led by Tsutomu Kume, Ph.D., professor of Medicine in the Division of Cardiology and of Pharmacology, have identified novel genetic mechanisms that regulate blood vessel growth in the ...

Please provide your email address to receive an email when new articles are posted on . EXN407 met primary endpoints of safety and tolerability and also demonstrated decreases in vascular leakage and ...

Please provide your email address to receive an email when new articles are posted on . According to Nayak, Axpaxli (axitinib intravitreal implant) is “a single injection, a single completely ...

More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...

NYU Grossman School of Medicine's Department of Ophthalmology has appointed Dimitra Skondra, MD, PhD, a distinguished retinal specialist and translational researcher, as vice chair of research. With a ...

SEATTLE -- A drug targeting senescent cells in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) produced mixed outcomes in two separate clinical trials. The 48-week ...

Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of ...

Active Phase 3 programs for DURAVYU in wet AMD and DME, the two largest multi-billion-dollar retinal disease markets –– Topline data for ...

The retina, as an accessible extension of the central nervous system, offers a unique window into the microvascular changes associated with Alzheimer’s disease. Recent studies have demonstrated that ...

Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are the leading causes of vision impairment in elderly patients and people living with diabetes, respectively.